Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
9
11
12
13
14
16
17
19
20
21
27
28
1
2
3
4
5
6
7
Psychiatry and Psychological Disorders
2021-02-08 - 2021-02-09    
All Day
Mental health Summit 2021 is a meeting of Psychiatrist for emerging their perspective against mental health challenges and psychological disorders in upcoming future. Psychiatry is [...]
Nanotechnology and Materials Engineering
2021-02-10 - 2021-02-11    
All Day
Nanotechnology and Materials Engineering are forthcoming use in healthcare, electronics, cosmetics, and other areas. Nanomaterials are the elements with the finest measurement of size 10-9 [...]
Dementia, Alzheimers and Neurological Disorders
2021-02-10 - 2021-02-11    
All Day
Euro Dementia 2021 is a distinctive forum to assemble worldwide distinguished academics within the field of professionals, Psychology, academic scientists, professors to exchange their ideas [...]
Neurology and Neurosurgery 2021
2021-02-10 - 2021-02-11    
All Day
European Neurosurgery 2021 anticipates participants from all around the globe to experience thought provoking Keynote lectures, oral, video & poster presentations. This Neurology meeting will [...]
Biofuels and Bioenergy 2021
2021-02-15 - 2021-02-16    
All Day
Biofuels and Bioenergy biofuel is a fuel that is produced through contemporary biological processes, such as agriculture and anaerobic digestion, rather than a fuel produced [...]
Tropical Medicine and Infectious Diseases
2021-02-15 - 2021-02-16    
All Day
Tropical Disease Webinar committee members invite all the participants across the globe to take part in this conference covering the theme “Global Impact on infectious [...]
Infectious Diseases 2021
2021-02-15 - 2021-02-16    
All Day
Infection Congress 2021 is intended to honor prestigious award for talented Young Researchers, Scientists, Young Investigators, Post-Graduate Students, Post-Doctoral Fellows, Trainees in recognition of their [...]
Gastroenterology and Liver Diseases
2021-02-18 - 2021-02-19    
All Day
Gastroenterology and Liver Diseases Conference 2021 provides a chance for all the stakeholders to collect all the Researchers, principal investigators, experts and researchers working under [...]
World Kidney Congress 2021
2021-02-18    
All Day
Kidney Meet 2021 will be the best platform for exchanging new ideas and research. It’s a virtual event that will grab the attendee’s attention to [...]
Agriculture & Organic farming
2021-02-22 - 2021-02-23    
All Day
                                                  [...]
Aquaculture & Fisheries
2021-02-22 - 2021-02-23    
All Day
We take the pleasure to invite all the Scientist, researchers, students and delegates to Participate in the Webinar on 13th World Congress on Aquaculture & [...]
Nanoscience and Nanotechnology 2021
2021-02-22 - 2021-02-23    
All Day
Conference Series warmly invites all the participants across the globe to attend "5th Annual Meet on Nanoscience and Nanotechnology” dated on February 22-23, 2021 , [...]
Neurology, Psychiatric disorders and Mental health
2021-02-23 - 2021-02-24    
12:00 am
Neurology, Psychiatric disorders and Mental health Summit is an idiosyncratic discussion to bring the advanced approaches and also unite recognized scholastics, concerned with neurology, neuroscience, [...]
Food and Nutrition 2021
2021-02-24    
All Day
Nutri Food 2021 reunites the old and new faces in food research to scale-up many dedicated brains in research and the utilization of the works [...]
Psychiatry and Psychological Disorders
2021-02-24 - 2021-02-25    
All Day
Mental health Summit 2021 is a meeting of Psychiatrist for emerging their perspective against mental health challenges and psychological disorders in upcoming future. Psychiatry is [...]
International Conference on  Biochemistry and Glyco Science
2021-02-25 - 2021-02-26    
All Day
Our point is to urge researchers to spread their test and hypothetical outcomes in any case a lot of detail as could be ordinary. There [...]
Biomedical, Biopharma and Clinical Research
2021-02-25 - 2021-02-26    
All Day
Biomedical research 2021 provides a platform to enhance your knowledge and forecast future developments in biomedical, bio pharma and clinical research and strives to provide [...]
Parasitology & Infectious Diseases 2021
2021-02-25    
All Day
INFECTIOUS DISEASES CONGRESS 2021 on behalf of its Organizing Committee, assemble all the renowned Pathologists, Immunologists, Researchers, Cellular and Molecular Biologists, Immune therapists, Academicians, Biotechnologists, [...]
Tissue Science and Regenerative Medicine
2021-02-26 - 2021-02-27    
All Day
Tissue Science 2021 proudly invites contributors across the globe to attend “International Conference on Tissue Science and Regenerative Medicine” during February 26-27, 2021 (Webinar) which [...]
Infectious Diseases, Microbiology & Beneficial Microbes
2021-02-26 - 2021-02-27    
All Day
Infectious diseases are ultimately caused by microscopic organisms like bacteria, viruses, fungi or parasites where Microbiology is the investigation of these minute life forms. A [...]
Stress Management 2021
2021-02-26    
All Day
Stress Management Meet 2021 will be a great platform for exchanging new ideas and research. It’s an online event which will grab the attendee’s attention [...]
Heart Care and Diseases 2021
2021-03-03    
All Day
Euro Heart Conference 2020 will join world-class professors, scientists, researchers, students, Perfusionists, cardiologists to discuss methodology for ailment remediation for heart diseases, Electrocardiography, Heart Failure, [...]
Gastroenterology and Digestive Disorders
2021-03-04 - 2021-03-05    
All Day
Gastroenterology Diseases is clearing a worldwide stage by drawing in 2500+ Gastroenterologists, Hepatologists, Surgeons going from Researchers, Academicians and Business experts, who are working in [...]
Environmental Toxicology and Ecological Risk Assessment
2021-03-04 - 2021-03-05    
All Day
Environmental Toxicology 2021 you can meet the world leading toxicologists, biochemists, pharmacologists, and also the industry giants who will provide you with the modern inventions [...]
Dermatology, Cosmetology and Plastic Surgery
2021-03-05 - 2021-03-06    
All Day
Market Analysis Speaking Opportunities Speaking Opportunities: We are constantly intrigued by hearing from professionals/practitioners who want to share their direct encounters and contextual investigations with [...]
Events on 2021-02-08
Events on 2021-02-18
Events on 2021-02-24
Events on 2021-03-03
Events on 2021-03-05
Latest News

Lexmark International, Announces financial results for the first quarter of 2015

lexmark healthcare

Lexmark reports first quarter results
— Delivered revenue and EPS at top of January guidance range
— Combined Enterprise Software and MPS revenue grew 13 percent year to year
— Annuity revenue grew 5 percent year to year, comprised 70 percent of Core revenue
— Annualized subscription contract value increased 108 percent year to year
— Deferred software revenue increased 35 percent year to year
— Paid 14th consecutive quarterly dividend and continued share repurchases
— Announced agreement to acquire Kofax Limited
Apr 28, 2015

LEXINGTON, Ky., April 28, 2015 — Lexmark International, Inc. today announced financial results for the first quarter of 2015.

“Despite a strong currency headwind, Lexmark delivered revenue and EPS at the top of our January guidance range,” said Paul Rooke, Lexmark chairman and chief executive officer. “Double-digit revenue growth in Higher Value Solutions is another clear indication that our transformation strategy is working.

“Our Annuity revenue represents approximately 70 percent of Core revenue, fueling Lexmark’s ability to invest in growing our Higher Value Solutions capabilities while also returning capital to shareholders through dividends and share repurchases.”

First Quarter Results

  • Delivered revenue and EPS at the top of the company’s January guidance range.

 

Revenue (millions) 1Q15 1Q14
    GAAP $852 $878
    Adjustments 3 3
    Non-GAAP1 $855 $881
EPS 1Q15 1Q14
    GAAP $0.32 $0.46
    Adjustments 0.49 0.46
    Non-GAAP $0.81 $0.92

 

First Quarter GAAP Results

  • Revenue of $852 million in 2015 compares to $878 million in 2014.
  • Gross profit margin of 38.7 percent compares to 38.9 percent in the same period last year.
  • Operating income margin was 5.0 and 6.1 percent in 2015 and 2014, respectively.
  • EPS of $0.32 in 2015 compares to $0.46 in the same period last year.

First Quarter Non-GAAP Results

  • Revenue of $855 million in 2015 compares to $881 million in 2014.
  • Core revenueof $807 million was about flat year to year, but grew 6 percent at constant currency3.
  • Gross profit margin of 40.5 percent compares to 41.0 percent in the same period last year.
  • Operating income margin was 9.5 percent and 10.4 percent in 2015 and 2014, respectively.
  • Adjusted EBITDA4 of $123 million in 2015 compares to $137 million in 2014.
  • Static non-GAAP tax rate is 30.0 percent, approximately flat with the year ago period. The company has adopted a static non-GAAP tax rate in order to provide investors a better understanding of Lexmark’s operations consistent with its long-term projections for mix of income among various taxing jurisdictions.
  • EPS of $0.81 in 2015 compares to $0.92 in the same period last year.

First Quarter Segment Revenue

  • Imaging Solutions and Services (ISS) revenue of $766 million declined 6 percent year to year.
    • Managed Print Services (MPS)5 revenue of $185 million grew 3 percent year to year.
    • Non-MPS6 revenue of $533 million declined 6 percent year to year.
    • Inkjet Exit7 revenue of $48 million declined 34 percent year to year.
  • Enterprise Software revenue was $86 million. Excluding adjustments, Enterprise Software revenue of $90 million grew 40 percent year to year.
    • Deferred software revenue8 increased 35 percent year to year.
    • Annualized subscription contract value9 increased 108 percent year to year.

First Quarter Higher Value Solutions Revenue

  • Lexmark’s Higher Value Solutions revenue10 is comprised of Enterprise Software and MPS.
  • Higher Value Solutions revenue excluding adjustments grew 13 percent year to year, accounting for 32 percent of total revenue, up from 28 percent in the same period in 2014.

First Quarter Annuity Revenue

  • Lexmark is growing a more predictable Annuity revenue11 base of laser supplies, Software maintenance, Software subscriptions and ISS extended warranty.
  • Lexmark’s Annuity revenue of $2.419 billion for the trailing four quarters grew 5 percent compared to the same period a year ago, and comprised 70 percent of Core revenue.

Free Cash Flow

  • The company delivered its 13th consecutive calendar year of positive free cash flow12 in 2014.
  • The company’s calendar year 2015 outlook for free cash flow remains at 90 to 100 percent of non-GAAP net income.
  • In the first quarter of 2015, free cash flow was -$47 million compared with -$34 million in the first quarter of 2014.
  • Cash, including cash equivalents and current marketable securities, was $797 million at quarter end, $779 million of which was non U.S.-based.

Transforming Lexmark, Driving Shareholder Value

  • Lexmark’s capital allocation framework delivers shareholder value through investments to build and grow Lexmark’s higher value software and solutions business, and through the return of capital to shareholders.
  • Lexmark’s target is to return, on average, more than 50 percent of free cash flow to shareholders through quarterly dividends and share repurchases, and the company has returned 86 percent since the first quarter of 2011.
  • In the first quarter, Lexmark returned $52 million to shareholders, which included paying the company’s 14th consecutive quarterly dividend amounting to $22 million, and share repurchases of $30 million (0.7 million shares).

Lexmark to Acquire Kofax

  • On March 24, 2015, Lexmark and Kofax Limited announced that the two companies entered into a merger agreement in which Lexmark will acquire Kofax for $11.00 per share in cash for a total enterprise value of approximately $1 billion.
  • Upon successful completion, Lexmark will nearly double the size of its Enterprise Software business.
  • In addition to the significant increase in scale, Kofax is expected to help accelerate the growth and significantly increase operating margins of Lexmark’s Enterprise Software business.
  • This acquisition will be funded with Lexmark’s non-U.S. cash and existing credit facilities, and will result in an enhanced, more efficient balance sheet benefiting from the deployment of available overseas cash and existing balance sheet capacity.
  • The acquisition demonstrates the continued execution of Lexmark’s capital allocation framework. The transaction will not impact Lexmark’s quarterly dividend, however share repurchases would be paused for 18 to 24 months while short term debt is paid.
  • The acquisition is expected to close in the second quarter of 2015 and is contingent on Kofax shareholder approval, applicable regulatory clearances, and customary closing conditions.

Lexmark Named an Industry Leader in Smart MFPs

  • Lexmark has once again been named as a leader in smart MFPs by IDC13.
  • IDC analyzes the strategies and current capabilities of companies providing smart MFPs.
  • As defined by the IDC MarketScape, leaders are companies that have led and continue to lead the market in both breadth of offering and strategic intent.
  • In addition to smart MFPs, IDC has also named Lexmark a leader in Managed Print Services14three consecutive times.

Looking Forward – Second Quarter of 2015

  • Core revenue is expected to be approximately flat year to year.
  • Total revenue is expected to decline in the range of 2 to 4 percent year to year.
  • GAAP EPS are expected to be around $0.07 to $0.17.
  • Non-GAAP EPS are expected to be around $0.75 to $0.85.

Looking Forward – Full Year of 2015

  • Core revenue is expected to decline slightly year to year.
  • Total revenue is expected to decline in the range of 3 to 5 percent year to year.
  • GAAP EPS are expected to be around $1.42 to $1.62.
  • Non-GAAP EPS are expected to be around $3.60 to $3.80.

Conference Call Today

  • The company will be hosting a conference call with securities analysts today at 8:30 a.m. (EDT). A live broadcast and a complete replay of this call can be accessed from Lexmark’s investor relations website at http://investor.lexmark.com. If you are unable to connect to the Internet, you can access the call via telephone at 888-693-3477 (outside the U.S. by calling 973-582-2710) using access code 18393863.
  • Lexmark’s earnings presentation slides, including reconciliations between GAAP and non-GAAP financial measures, will be available on Lexmark’s investor relations website prior to the live broadcast.

About Lexmark

Lexmark (NYSE: LXK) creates enterprise software, hardware and services that remove the inefficiencies of information silos and disconnected processes, connecting people to the information they need at the moment they need it. Open the possibilities at www.Lexmark.com.

Lexmark, the Lexmark logo and Open the possibilities are trademarks of Lexmark International, Inc., registered in the U.S. and/or other countries. All other trademarks are the property of their respective owners.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements in this release which are not historical facts are forward-looking and involve risks and uncertainties which may cause the company’s actual results or performance to be materially different from the results or performance expressed or implied by the forward-looking statements. Factors that may impact such forward-looking statements include, but are not limited to, fluctuations in foreign currency exchange rates; failure to successfully integrate newly acquired businesses; continued economic uncertainty related to volatility of the global economy; inability to execute the company’s strategy to become an end-to-end solutions provider; decreased supplies consumption; possible changes in the size of expected restructuring costs, charges, and savings; market acceptance of new products; aggressive pricing from competitors and resellers; changes in the company’s tax provisions or tax liabilities; excessive inventory for the company’s reseller channel; failure to manage inventory levels or production capacity; periodic variations affecting revenue and profitability; inability to realize all of the anticipated benefits of the company’s acquisitions; the failure of information technology systems, including data breaches or cyberattacks; the inability to develop new products and enhance existing products to meet customer needs on a cost competitive basis; reliance on international production facilities, manufacturing partners and certain key suppliers; business disruptions; increased competition in the aftermarket supplies business; inability to obtain and protect the company’s intellectual property rights and defend against claims of infringement and/or anticompetitive conduct; ineffective internal controls; customer demands and new regulations related to conflict-free minerals; fees on the company’s products or litigation costs required to protect the company’s rights; inability to perform under managed print services contracts; the inability to attract, retain and motivate key employees; terrorist acts; acts of war or other political conflicts; increased investment to support product development and marketing; the financial failure or loss of business with a key customer or reseller; credit risk associated with the company’s customers, channel partners, and investment portfolio; the outcome of litigation or regulatory proceedings to which the company may be a party; unforeseen cost impacts as a result of new legislation; changes in a country’s political or economic conditions; disruptions at important points of exit and entry and distribution centers; and other risks described in the company’s Securities and Exchange Commission filings. The company undertakes no obligation to update any forward-looking statement.

(1)    In an effort to provide investors with additional information regarding the company’s results as determined by generally accepted accounting principles (GAAP), the company has also disclosed in this press release non-GAAP financial measures such as EBITDA, Adjusted EBITDA, earnings per share amounts and related income statement items which management believes provides useful information to investors. When used in this press release, “non-GAAP” Adjusted EBITDA, earnings per share amounts and related income statement items exclude restructuring charges and project costs, acquisition and divestiture-related adjustments and pension plan actuarial gains/losses. The rationale for management’s use of non-GAAP measures is included in Appendix A to the financial information attached hereto.
(2)    Core revenue is defined as total Lexmark revenue minus Inkjet Exit revenue.
(3)    Constant currency is calculated by adjusting current year and prior year results to remove estimated currency rate impacts and related hedge gains and losses.
(4)    Adjusted EBITDA is defined as net earnings plus net interest expense (income), provision for  income taxes, depreciation and amortization, excluding restructuring charges and project costs, acquisition and divestiture related adjustments and pension plan actuarial gains or losses.
(5)    MPS revenue is defined as ISS laser hardware, supplies and fleet management solutions sold through a managed print services agreement.
(6)    Non-MPS revenue is defined as ISS laser hardware, laser supplies, dot matrix hardware, and dot matrix supplies not sold as a part of an MPS agreement. Non-MPS also includes parts and service related to hardware maintenance.
(7)    Inkjet Exit is defined as consumer and business inkjet hardware and supplies that the company is exiting.
(8)    Deferred software revenue is defined as amounts billed to customers but not yet recognized as software revenue.
(9)    Annualized subscription contract value indicates value for the upcoming four quarters.
(10)  Higher Value Solutions revenue is defined as combined MPS and Enterprise Software revenue.
(11)  Annuity revenue includes laser supplies, laser extended warranty, software subscriptions, and software maintenance for the trailing four quarters.
(12)  Free cash flow is defined as net cash flows provided by operating activities minus purchases of property, plant and equipment plus proceeds from sale of fixed assets.
(13)  IDC MarketScape: U.S. “Smart” Multifunction Peripheral 2014 – 2015 Vendor Assessment, doc #254761, March 2015.
(14)  IDC MarketScape: Worldwide Managed Print and Document Services 2014 Vendor Assessment – Focus on Managed Workflow Services September 2014, IDC #250631

 

 

LEXMARK INTERNATIONAL, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS
(In Millions, Except Per Share Amounts)
(Unaudited)
Three Months Ended
March 31
2015 2014
Revenue:
Product $     714.7 $     763.6
Service 137.3 114.1
Total Revenue 852.0 877.7
Cost of revenue:
Product 428.4 445.6
Service 93.6 83.9
Restructuring-related costs 0.1 6.6
Total Cost of revenue 522.1 536.1
Gross profit 329.9 341.6

Source